• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
Liu Yin, Zhao Bin, Xie Yu-sai, Yang Tao. Screening and bioinformatics analysis of IgA nephropathy gene based upon GEO database[J]. Journal of Clinical Nephrology, 2021, 21(3): 194-198. DOI: 10.3969/j.issn.1671-2390.m20-132
Citation: Liu Yin, Zhao Bin, Xie Yu-sai, Yang Tao. Screening and bioinformatics analysis of IgA nephropathy gene based upon GEO database[J]. Journal of Clinical Nephrology, 2021, 21(3): 194-198. DOI: 10.3969/j.issn.1671-2390.m20-132

Screening and bioinformatics analysis of IgA nephropathy gene based upon GEO database

More Information
  • Received Date: June 22, 2020
  • Available Online: May 11, 2023
  • Published Date: March 27, 2021
  • Objective To identify novel biomarkers of IgA nephropathy(IgAN) through bioinformatics analysis and elucidate the possible molecular mechanism of IgAN.Methods The microarray datasets of GSE104948,GSE93798 and GSE37460 containing IgAN patients and healthy controls were downloaded from the GEO database and analyzed by using the limma R package for obtaining differentially expressed genes.Then GO and KEGG pathway enrichment analyses were performed.And STRING and Cytoscape software were utilized for constructing protein interaction networks for elucidating the molecular mechanism of IgAN.Results Thirty DEGs were identified,including 16 up-regulated genes and 14 down-regulated genes.Up-regulated genes such as FN1 and COL1A2 are mainly involved in extracellular matrix receptor interaction and PI3K-Akt signaling pathway.ALB gene was significantly down-regulated in IgA nephropathy.And FN1,COL1A2,ALB and FABP genes were screened as hub genes.Conclusion FN1,COL1A2,ALB and FABP genes may play an important role in the development of IgA nephropathy and serve as potential molecular targets for diagnosing and treating IgAN.
  • [1]
    Rodrigues JC,Haas M,Reich HN.IgA Nephropathy[J].Clinical journal of the American Society of Nephrology:CJASN,2017,12(4):677-86.DOI: 10.2215/cjn.07420716.
    [2]
    Donadio JV,Grande JP.IgA nephropathy[J].The New England journal of medicine,2002,347(10):738-48.DOI: 10.1056/NEJMra020109.
    [3]
    Wyatt RJ,Julian BA.IgA nephropathy[J].The New England journal of medicine,2013,368(25):2402-14.DOI: 10.1056/NEJMra1206793.
    [4]
    Cui HX,Zhang YX,Zhang QJ,et al.A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma[J].Cancer Med,2017,6(12):2932-2941.DOI: 10.1002/cam4.1180.
    [5]
    Tian W,Liu J,Pei BJ,et al.Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer[J].Oncol Rep,2016,35(4):2171-2176.DOI: 10.3892/or.2016.4561.
    [6]
    Zhou LT,Qiu S,Lv LL,et al.Integrative bioinformatics analysis provides insight into the molecular mechanisms of chronic kidney disease[J].Kidney Blood Press Res,2018,43(2):568-581.DOI: 10.1159/000488830.
    [7]
    Shu BY,Fang Y,He WC,et al.Identification of macrophage-related candidate genes in lupus nephritis using bioinformatics analysis[J].Cell Signal,2018,46:43-51.DOI: 10.1016/j.cellsig.2018.02.006.
    [8]
    Grayson PC,Eddy S,Taroni JN,et al.Metabolic pathways and immunometabolism in rare kidney diseases[J].Ann Rheum Dis,2018,77(8):1226-1233.DOI: 10.1136/annrheumdis-2017-212935.
    [9]
    Liu PD,Lassén E,Nair V,et al.Transcriptomic and proteomic profiling provides insight into mesangial cell function in IgA nephropathy[J].J Am Soc Nephrol,2017,28(10):2961-2972.DOI: 10.1681/ASN.2016101103.
    [10]
    Guo FF,Zhang W,Su J,et al.Prediction of drug positioning for Quan-du-Zhong capsules against hypertensive nephropathy based on the robustness of disease network[J].Front Pharmacol,2019,10:49.DOI: 10.3389/fphar.2019.00049.
    [11]
    Diboun I,Wernisch L,Orengo CA,et al.Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma[J].BMC Genomics,2006,7:252.DOI: 10.1186/1471-2164-7-252.
    [12]
    Huang DW,Sherman BT,Tan QN,et al.The DAVID Gene Functional Classification Tool:a novel biological module-centric algorithm to functionally analyze large gene lists[J].Genome Biol,2007,8(9):R183.DOI: 10.1186/gb-2007-8-9-r183.
    [13]
    Szklarczyk D,Morris JH,Cook H,et al.The STRING database in 2017:quality-controlled protein-protein association networks,made broadly accessible[J].Nucleic Acids Res,2017,45(D1):D362-D368.DOI: 10.1093/nar/gkw937.
    [14]
    Kohl M,Wiese S,Warscheid B.Cytoscape:software for visualization and analysis of biological networks[J].Methods Mol Biol,2011,696:291-303.DOI: 10.1007/978-1-60761-987-1_18.
    [15]
    Chin CH,Chen SH,Wu HH,et al.cytoHubba:identifying hub objects and sub-networks from complex interactome[J].BMC Syst Biol,2014,8(Suppl 4):S11.DOI: 10.1186/1752-0509-8-S4-S11.
    [16]
    Ebefors K,Liu PD,Lassén E,et al.Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1[J].BMC Nephrol,2016,17:40.DOI: 10.1186/s12882-016-0251-5.
    [17]
    Cederholm B,Wieslander J,Bygren P,et al.Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy[J].Proc Natl Acad Sci USA,1988,85(13):4865-4868.DOI: 10.1073/pnas.85.13.4865.
    [18]
    Misaki T,Naka,Kuroda K,et al.Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients[J].Clin Exp Nephrol,2015,19(5):844-850.DOI: 10.1007/s10157-014-1072-0.
    [19]
    Kawai Y,Masutani K,Torisu K,et al.Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy:a possible role of albumin as an antioxidant agent[J/OL].PLoS One,2018,13(5):e0196655.DOI: 10.1371/journal.pone.0196655.
    [20]
    Mori Y,Masuda T,Kosugi T,et al.The clinical relevance of plasma CD147/basigin in biopsy-proven kidney diseases[J].Clin Exp Nephrol,2018,22(4):815-824.DOI: 10.1007/s10157-017-1518-2.
    [21]
    Liao YX,Zhang ZP,Zhao J,et al.Effects of fibronectin 1 on cell proliferation,senescence and apoptosis of human glioma cells through the PI3K/AKT signaling pathway[J].Cell Physiol Biochem,2018,48(3):1382-1396.DOI: 10.1159/000492096.
    [22]
    Shui HA,Ka SM,Lin JC,et al.Fibronectin in blood invokes the development of focal segmental glomerulosclerosis in mouse model[J].Nephrol Dial Transplant,2006,21(7):1794-1802.DOI: 10.1093/ndt/gfl113.
    [23]
    Altunkova I,Minkova V,Belovezhdov N.Role of fibronectin in immune glomerulonephritis[J].Nephron,1993,63(4):438-444.DOI: 10.1159/000187249.
    [24]
    Coppo R,Camilla R,Amore A,et al.Oxidative stress in IgA nephropathy[J].Nephron Clin Pract,2010,116(3):c196-c198,discussionc199.DOI: 10.1159/000317199.
    [25]
    Remuzzi G,Bertani T.Pathophysiology of progressive nephropathies[J].N Engl J Med,1998,339(20):1448-1456.DOI: 10.1056/NEJM199811123392007.
    [26]
    Eddy AA.Proteinuria and interstitial injury[J].Nephrol Dial Transplant,2004,19(2):277-281.DOI: 10.1093/ndt/gfg533.

Catalog

    Article views (367) PDF downloads (261) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return